Euzebiusz Jamrozik
Overview
Explore the profile of Euzebiusz Jamrozik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson T, Jamrozik E, Ramachandran P, Johnson S
J Med Microbiol
. 2025 Feb;
74(2).
PMID: 40013924
Metagenomics is increasingly used for diagnosis in hospital settings. It is useful particularly in cases of unknown aetiology, where novel or difficult-to-diagnose pathogens are suspected, and/or following unexplained disease outbreaks....
2.
Toomey D, Adams-Phipps J, Wilkinson J, Pietro J, Littman J, Kamenicek S, et al.
BMJ Open
. 2025 Feb;
15(2):e085250.
PMID: 39920069
Objectives: Controlled human infection studies (CHIS) involve intentional exposure of human volunteers to infectious agents. A previous systematic review found that adverse event (AE) reporting across CHIS is inconsistent, which...
3.
Muhi S, Schmidt S, Marshall J, OBrien D, Johnson P, McCarthy J, et al.
PLoS Negl Trop Dis
. 2025 Feb;
19(2):e0012593.
PMID: 39908304
Background: Infection with Mycobacterium ulcerans causes slowly progressive skin lesions known as Buruli ulcer (BU). An M. ulcerans controlled human infection model (MuCHIM) is likely to accelerate our understanding of...
4.
Righi E, Yahav D, Nasim A, Akova M, Barac A, Scudeller L, et al.
Clin Microbiol Infect
. 2025 Jan;
PMID: 39827993
Background: Incorporating ethics into clinical practice guidelines (CPGs) can be challenging. This is particularly evident for infectious diseases (ID) CPGs because of the complexity of ID ethics (IDE) and the...
5.
Williams E, Hocking J, Fairley C, Chen M, Williamson D, McCarthy J, et al.
J Infect Dis
. 2025 Jan;
PMID: 39825788
Infection with Neisseria gonorrhoeae, the causative agent of gonorrhoea, causes significant morbidity worldwide and can have long-term impacts on reproductive health. The greatest global burden of gonorrhoea occurs in low-...
6.
Gur-Arie R, Kraaijeveld S, Jamrozik E
Wellcome Open Res
. 2024 Oct;
6:252.
PMID: 39445230
COVID-19 vaccination of children has begun in various high-income countries with regulatory approval and general public support, but largely without careful ethical consideration. This trend is expected to extend to...
7.
Muhi S, Marshall J, OBrien D, Johnson P, Ross G, Ramakrishnan A, et al.
Wellcome Open Res
. 2024 Oct;
9:488.
PMID: 39386965
Critical knowledge gaps have impeded progress towards reducing the global burden of disease due to , the cause of the neglected tropical disease Buruli ulcer (BU). Development of a controlled...
8.
Robertson D, Heriot G, Jamrozik E
J Eval Clin Pract
. 2024 Apr;
30(4):625-631.
PMID: 38562003
Background: "Herd immunity" became a contested term during the COVID-19 pandemic. Although the term "herd immunity" is often used to refer to thresholds at which some diseases can be eliminated...
9.
Kraaijeveld S, Gur-Arie R, Jamrozik E
J Ethics
. 2024 Feb;
28(1):145-169.
PMID: 38375445
Should people get vaccinated for the sake of others? What could ground-and limit-the normative claim that people ought to do so? In this paper, we propose a reasons-based consequentialist account...
10.
Jamrozik E, Littler K, Meln I, Van Molle W, Morel S, Olesen O, et al.
Biologicals
. 2024 Feb;
85:101748.
PMID: 38350349
Controlled Human Infectious Model studies (CHIM) involve deliberately exposing volunteers to pathogens. To discuss ethical issues related to CHIM, the European Vaccine Initiative and the International Alliance for Biological Standardization...